New data has become available from a CheckMate -205 multi-cohort Phase II trial for Bristol-Myers Squibb’s Opdivo this past week. Read More »

Aetna recently published a blog on its website indicating the importance of accountable care organizations (ACO).  Read More »

A bipartisan bill introduced this week in the Senate would allow generic drug companies to sue the brand-name marketplace giants for samples and safety protocols. Read More »

AbbVie this week announced the recipients of its Crohn’s & Colitis Scholarship and its Rheumatology Scholarship. Read More »

Endo Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has informed the company that an Advisory Committee will be meeting on its supplemental new drug application for OPANA ER. Read More »

ACADIA Pharmaceuticals Inc. announced this week that it will be presenting information during the JMP Securities Life Sciences Conference that is set to take place on Tuesday in New York City. Read More »

The American Society of Health-System Pharmacists (ASHP) announced this week that it has awarded Geisinger Health System with its Board of Directors Award of Excellence during the ASHP Summer Meetings. Read More »

The American Society of Health-System Pharmacists (ASHP) announced this week that it has approved a measure that urges Congress to ban advertisements for prescription medication and related devices.   Read More »

Data from safety, comparable efficacy and immunogenicity studies on Biogen biologics, Benepali and Flixabi, were featured during the Annual European Congress of Rheumatology (EULAR 2016) this past week. Read More »

The American Society of Health-System Pharmacists (ASHP) announced Wednesday that Lisa Gersema was selected as the organization’s president during its Summer Meetings and Exhibition in Baltimore. Read More »

The Pharmaceutical Care Management Association (PCMA) this week announced the next part of its campaign that explains the functions of pharmacy benefit managers (PBM). Read More »

Onzetra Xsail from Avanir Pharmaceuticals Inc. was featured in presentations during the American Headache Society Annual Scientific Meeting that took place this past week in San Diego. Read More »

Biotie Therapies Corp. announced on Monday that it has officially delisted its American depository shares (ADS) from the NASDAQ Global Select Market (NASDAQ US). Read More »

Acura Pharmaceuticals Inc. announced that clinical study results have indicated that its LIMITX technology in deterrence medication has been shown to have positive, the company announced this past week. Read More »

Data from clinical studies from medications in development from Allergan will be presented during the American Society for Microbiology (ASM) Microbe event that will be taking place this week. Read More »

Allergan has announced its support for a public service announcement (PSA) to help those caring for someone with Alzheimer’s disease that is being launched by the Alzheimer’s Foundation of America (AFA) on Tuesday. Read More »

Minnesota’s UnitedHealth Group, based in Minnetonka, recently recalibrated its leadership team as it forges ahead with new products and services to serve its members with the latest developments in medical care coverage and benefits. Read More »

Zealand announced that data on its iGlarLixi drug candidates are being presented recently during the American Diabetes Association’s (ADA) Scientific Sessions. Read More »

Data from research on AbbVie candidate medications was featured during the European Hematology Association (EHA) Annual Congress that took place in Denmark this past week. Read More »

Pfizer recently announced that several studies and analyses for its tofacitinib citrate (XELJANZ) treatment for rheumatoid arthritis (RA) will be featured at the European League Against Rheumatism Annual Congress (EULAR 2016). Read More »